GP Chemotherapy in Combination With Anti-PD-1 and Anti-TIGIT in Unresectable Advanced BTC

NCT05023109 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Carcinoma

Interventions

DRUG: GP+PD-1+Tight

Sponsor

Shanghai Zhongshan Hospital

Collaborators

[object Object]
[object Object]